Manel Esteller, Director of the Cancer Epigenetics and Biology Program at Josep Carreras Leukaemia Research Institute, shared on X:
“Explaining at the ‘Initiation and plasticity’ session of WCLC2026 IASLC that a significant fraction of cancer of unknown primary CUP are occult non-small cell lung cancer.”
You can also read:
Advancing Innovation in Small Cell Lung Cancer at WCLC 2026 – Amgen
